THERAPIES - SOMMAIRE JUILLET AOUT 2022

THERAPIES - SOMMAIRE JUILLET AOUT 2022

Le numéro 4  (juillet aout 2022) est en ligne

Consultez le sommaire ici

Editorial

·Histoire de la pharmacologie médicale lilloise

Régis Bordet, pharmacologie médicale lilloise

Pharmacovigilance

·Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children

Nicolas Pages, Anissa Bounabi, Inesse Boussaha, Marietou Ndiaye, Aurélie Portefaix, Gaelle Simeon, Claire Guy, Jean Stagnara, Nathalie Paret, Thierry Vial, Pirayeh Eftekhari, Daniel Floret, Vincent Gajdos, Jean-Paul Langhendries, Nathalie Bleyzac, Corinne Alberti, Evelyne Jacqz-Aigrain, Kim An Nguyen, Behrouz Kassai, EREMI Group

·Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss – An observational study using the EFEMERIS database

Clémentine Vabre, Mélanie Araujo, Christine Damase-Michel, Caroline Hurault-Delarue, Isabelle Lacroix

Clinical pharmacology

Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials

Sophie Sun, Lucie Hisland, Guillaume Grenet, François Gueyffier, Catherine Cornu, Nemat Jaafari, Rémy Boussageon

·Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives

Aishwarya Shinde, Kanan Panchal, Sumeet Katke, Rishi Paliwal, Akash Chaurasiya

·Replacing liquid with solid dosage forms in pediatric practice: Feasibility and economic impact from a hospital-based study

Rama Arab, Behrouz Kassai, Roubi Kilo, Catherine Cornu, Elisabete Gomes, EREMI group, Tristan Dagonneau

Pharmacoepidemiology

·A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients

Saeed Nateghi, Mohammad Mahmoudi Gomari, Hadiseh Hosamirudsari, Behnam Behnoush, Asma Razmjoofard, Goli Azimi, Shokooh Ordookhani, Ali Jafarpour, Neda Faraji

Pharmacokinetics

·Is there a ceiling lamotrigine serum level in epileptic children in remission?

Rim Charfi, Emna Gaies, Mouna Ben Sassi, Hanene El Jebari, Rania Kammoun, Israa Dahmene, Nadia Jebabli, Issam Salouage, Riadh Daghfous, Sameh Trabelsi

Social pharmacology

·Penetration rate of anti-TNF biosimilars and savings at 5 years after their introduction in French hospitals

Quentin Jarrion, Brahim Azzouz, James Robinson, Damien Jolly, Catherine Vallet, Thierry Trenque

·Parental self-medication with antibiotics in a Tunisian pediatric center

Asma Ben Mabrouk, Fatma Larbi Ammari, Amina Werdani, Nesrine Jemmali, Jihene Chelli, Houcem Elomma Mrabet, Ahmed Rassas, Mohamed Habib Sfar, Sana El Mhamdi, Bahri Mahjoub

Letters to editor

·The first case of leflunomide-induced discoid lupus erythematosus

Hanene Lassoued Ferjani, Hiba Boussaa, Kaouther Maatallah, Dhia Kaffel, Wafa Hamdi

·Idiopathic non-cirrhotic portal hypertension (INCPH) during azathioprine treatment in patient with Crohn's disease: A case report

Khaoula Chabbouh, Douha Cherif, Habiba Debbabi, Hela Kchir, Hejer Hassine, Syrine Ben-Hammamia, Ghozlane Lakhoua, Abdelkader Jarray, Wassim Frikha, Beya Chelly, Sihem El-Aidli, Habiba Mizouni, Slim Haouet, Nadia Maamouri

·Time to define common European criteria for therapeutic added value

Denis Boucaud-Maitre, Francesco Salvo, Driss Berdaï

·DRESS syndrome sous phénobarbital : une réaction d’hypersensibilité aux médicaments, connue mais oubliée des prescripteurs–à propos d’un cas

Camille Douilly, Elise Lepoix, Brahim Azzouz, Aurore Morel, Thierry Trenque

·Dronabinol et syndrome d’hyperémèse cannabinoïde : un risque potentiel ?

Amélie Boursier, Clément Caron, Joelle Dekemp, Vassili Fague, Julie Fulcrand, Eugénie Boccara, Anne-Sylvie Caous, Antoine Lemaire

·Flu vaccine-induced purpura annularis telangiectodes of Majocchi

Massara Baklouti, Khadija Sellami, Rim Chaabouni, Abderrahmen Masmoudi, Mouna Daldoul, Serria Hammami, Slim Charfi, Khaled Zghal, Tahia Sellami, Hamida Turki